Thursday, October 14, 2021

News

FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19

The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients with positive results of direct SARS-CoV-2...

Pfizer files with FDA for emergency use of its COVID-19 vaccine in US

Pfizer Inc. and its German partner, BioNTech SE will submit a request today to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of their mRNA vaccine candidate, BNT162b2 against SARS-CoV-2, which will potentially enable...

Pfizer’s COVID-19 shot 95% effective, seeking FDA clearance soon

In a press release issued today, Pfizer said that new test results show its coronavirus vaccine is 95% effective, is safe and also protects older people most at risk of dying — the last data needed to...

Moderna says its COVID-19 vaccine is 94.5% effective

Moderna said its experimental coronavirus vaccine was nearly 95 percent effective in a pivotal study. The NIH-appointed Data Safety Monitoring Board (DSMB) informed Moderna that the trial has met the statistical criteria pre-specified in the study protocol for...

DoorDash Files IPO, Under Ticker DASH on NYSE

Delivery giant DoorDash Inc. is planning to sell its stock to the public, capitalizing on the growing trend of consumers embracing app-based deliveries with many at home during the pandemic. The company made its...

Major death spikes as the U.S. adds 143,000 COVID-19 cases

Updated data from researchers at John Hopkins University showed 143,200 cases were added on Wednesday, topping the record set the day before by almost 3,000 cases. Wednesday was the fifth single-day case record in nine days.

Analysts predict Pfizer, BioNTech set to make billions in yearly sales with COVID-19 vaccine launch

In a note to clients Tuesday, SVB Leerink analyst Geoffrey Porges said the recent results from Pfizer's early COVID-19 vaccine data should “boost confidence of the general public in COVID vaccines, which should drive up the early adoption rate.” The analysts see Pfizer’s...

Biden names members of COVID-19 advisory task force; taps BARDA whistleblower Rick Bright

President-elect Joe Biden hit the ground running Monday morning with an announcement of his transition team’s COVID-19 advisory board.  The advisory board will be co-chaired by public health experts including Rick Bright, a vaccine expert and the former...

Early Data Shows Pfizer’s COVID-19 Vaccine is 90% Effective

Pfizer and its partner BioNTech, has released promising interim data from the Phase III COVID-19 vaccine trial. The data suggest a 90% efficacy rate for the vaccine. Initially, the plan was to conduct...

Joe Biden elected 46th president of United States, after sealing 270 Electoral College Votes

The Associated Press declared the former vice president Joe Biden as the winner of his native Pennsylvania at 11:25 a.m. EST. With his victory, Kamala Harris becomes the first woman to be elected vice president. She's also the...
- Advertisement -

Latest News

BioBiz: Immusoft inks deal with Takeda Pharma; Affyimmune closes $30M Series A Funding

Rare disease therapy developer, Immusoft, has signed a licensing agreement with Takeda Pharmaceutical with a total potential...
- Advertisement -

WHO recommends groundbreaking malaria vaccine for African children at risk

The World Health Organization on Wednesday endorsed the malaria vaccine Mosquirix, the first step in a process that should lead to wide...

COVID-19’s Vaccine and Drug Innovators Chosen as Recipients of the Galien Foundation 2021 Roy Vagelos Pro Bono Humanum Award for Global Health Equity

The Prix Galien Awards Committee announced that six world-leading biopharma companies responsible for the development of COVID-19 vaccines and therapeutics will jointly...

Pfizer’s COVID-19 vaccine to garner full FDA approval next week

According to media reports, the Food and Drug Administration is pushing to approve Pfizer-BioNTech’s two-dose Covid-19 vaccine by early next week, further...

WWE® issues John Cena NFTs Leading Into SummerSlam

The WWE will create non-fungible-tokens (NFTs) inspired by WWE Superstar John Cena, along with never-before-sold memorabilia and experiences, just in time for...